Equity | Note 6. Equity The Company is currently authorized to issue up to 200,000,000 0.0001 20,000,000 0.0001 2023 On June 19, 2022, the Company entered into a one-year contract with SRAX, Inc. (“SRAX”). In exchange for the right to use the SRAX Sequire platform, in connection with the Company’s Regulation A Offering, the Company agreed to issue SRAX 1,250,000 shares of its restricted common stock. Per the agreement, the shares are subject to a price adjustment if the Company issues any common stock or common stock equivalents less than $1.00 per share. On July 13, 2022, the Company issued 1,250,000 1,250,000 572,917 677,083 0 572,917 On February 24, 2023, the Board approved the issuance of 100,000 100,000 On May 23, 2023, the Board approved the issuance of 300,000 300,000 On July 10, 2023, the Company issued 300,040 300,000 On December 10, 2023, the Board approved the issuance of 450,000 45,000 On December 18, 2023, the Company sold 4 Units at a price of $ 10,000 40,000 100,000 50,000 1.00 2022 On February 8, 2022, the Board approve the issuance of 2,975,000 445,953 On December 14, 2022, the Board approved the issuance of 600,000 599,940 During the year ended December 31, 2022, the Company issued 2,000 1,990 Stock Warrants The following table summarizes the stock warrant activity for the years ended December 31, 2023 and 2022: Schedule of stock warrant activity Number of Warrants Weighted Average Exercise Price Per Share Outstanding at December 31, 2021 1,487,500 $ 2.00 Granted – – Exercised – – Forfeited and expired – – Outstanding at December 31, 2022 1,487,500 2.00 Granted 200,000 1.00 Exercised – – Forfeited and expired – – Outstanding at December 31, 2023 1,687,500 $ 1.88 As of December 31, 2023, all outstanding warrants are exercisable and have a weighted average remaining term of 1.1 no Stock Options The following table summarizes the stock option activity for the years ended December 31, 2023 and 2022: Schedule of stock option activity Number of Options Weighted Average Exercise Price Per Share Outstanding at December 31, 2021 3,750,000 $ 0.10 Granted 300,000 0.20 Exercised – – Forfeited and expired – – Outstanding at December 31, 2022 4,050,000 0.11 Granted 4,300,000 0.10 Exercised – – Forfeited and expired – – Outstanding at December 31, 2023 8,350,000 $ 0.10 On December 10, 2023, the Company granted 300,000 0.10 27,339 0.10 0.10 10 128.26 4.28 0 During the year ended December 31, 2023, the Company recognized $ 353,508 711,811 8.87 On December 14, 2022, the Company granted 300,000 0.20 43,048 1.00 0.20 10 126.98 3.49 0 During the year ended December 31, 2022, the Company recognized $ 252,373 673,781 8.69 187,500 |